Several immunohistochemical studies have demonstrated that PKCα is overexpressed in high-grade bladder, prostate, and endometrial cancers, whereas breast, colon, and basal cell cancers display downregulation of PKCα expression [21]. This evidence concerns the gene PRKCA and endometrial cancer.